Apoptosis of smooth muscle cells (SMC) in atherosclerotic vessels can desta
bilize the atheromatus plaque and result in rupture, thrombosis, and sudden
death. In efforts to understand the molecular processes regulating apoptos
is in this cell type, we have defined a novel mechanism involving the ubiqu
itously expressed transcription factor Sp1. Subtypes of SMC expressing abun
dant levels of Spl produce the death agonist, Fas ligand (FasL) and undergo
greater spontaneous apoptosis, Sp1 activates the FasL promoter via a disti
nct nucleotide recognition element whose integrity is crucial for inducible
expression. Inducible FasL promoter activation is also inhibited by a domi
nant-negative form of Sp1, Increased SMC apoptosis is preceded by Sp1 phosp
horylation, increased FasL transcription, and the autocrine/ paracrine enga
gement of FasL with its cell-surface receptor, Fas, Inducible FasL transcri
ption and apoptosis are blocked by dominant-negative protein kinase C-zeta,
whose wild-type counterpart phosphorylates Sp1. Thus, Sp1 phosphorylation
is a proapoptotic transcriptional event in vascular SMC and, given the wide
distribution of this housekeeping transcription factor, may be a common re
gulatory theme in apoptotic signal transduction.